ABSTRACT. A child presented in early childhood with episodes of coma and hypoglycemia and a rapidly evolutive myopathy and cardiomyopathy leading to death at 9 mo of age. Ketosis was decreased (blood P-hydroxybutyrate: 0.07 mmol/L) despite normal plasma levels of fatty acids (0.81 mmol/L). The patient's urine contained excessive amounts of the Cs to Clo dicarboxylic acids present in almost all defects of fatty acid mitochondrial oxidation. More specifically, gas chromatography-mass spectrometry identified an accumulation of medium-and long-chain (Cs to C14) 3-hydroxy-dicarboxylic acids, suggesting a defect of the mitochondrial enzyme that normally dehydrogenates these 3-hydroxyacyl-CoA esters. Biochemical studies in the patient's cultured fibroblasts confirmed the impairment of medium-and long-chain fatty acid oxidation, and allowed the recognition of the deficiency of long-chain 3-hydroxyacyl-CoA dehydrogenase. The activities of long-, medium-, and short-chain acyl-CoA dehydrogenases and 3-ketoacylCoA thiolase were normal. These results describe a disorder of fatty acid metabolism that affects the liver, skeletal muscles, and myocardium. It is important to point out that long-chain 3-hydroxyacyl-CoA deficiency shares many clinical similarities with systemic carnitine deficiency, as well as with carnitine-palmityl-CoA transferase and longchain acyl-CoA dehydrogenase deficiencies. The differential diagnosis of this disease relies on the demonstration of long-chain urinary dicarboxylic acids with a hydroxyl group in 3-position and the study of the enzyme activity in cultured fibroblasts. (Pediatr Res 28: 657-662, 1990) 
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Our report describes one of these patients, who developed recurrent hypoglycemia in early childhood and died at 9 mo of age from a rapidly progressive myopathy and cardiomyopathy, in whom biochemical studies demonstrated a specific defect of long-chain 3-hydroxyacyl-CoA dehydrogenase.
CASE REPORT
This female patient was first admitted to the HBpital Saint Vincent de Paul of Paris at 9 mo of age because of major muscular weakness. Her parents were French caucasians and were considered in good health. The family medical history was entirely negative. The patient was the 3040-g product of a normal first pregnancy and, except for frequent upper respiratory tract infections, had been well, with normal growth and early development. At 5 mo of age, she developed fever (40°C) and started vomiting 2 h after the evening meal and with irritability and Abbreviations e~c i t a t i~n before going to bed; At 0600 h, she was found unarousable in bed, with major hypotonia. She was admitted to a CoA, coenzyme A country hospital, where blood glucose was found at 20 mg/dL LCAD, long-chain acyl-CoA dehydrogenase (1.12 mmol/L), was ressuscitated with i.v. glucose, and dis-MCAD, medium-chain acyl-CoA dehydrogenase charged without further investigation. One mo later, she was SCAD, short-chain acyl-CoA dehydrogenase readmitted in the Children's Hospital of Montpellier with early morning coma and generalized seizures. Temperature was 37°C. At admission, blood glucose was 30 mg/dL (1.7 mmol/L). After correction of the hypoglycemia, the findings of the examination were unremarkable except for hypotonia and muscular weakness. Defects of the mitochondrial oxidation of fatty acids represent plasma insulin, growth hormone, and cortisol were normal, ~h~ a newly recognized area of inborn errors of metabolism (1, 2). girl was otherwise alert with normal cognitive development. After their carnitine-dependent transfer through the mitochon-
The child was referred 3 mo later to saint vincent de paul drial membranes, acyl-COA esters are oxidized through four Hospital because of a major deterioration of her status associated initial steps mediated by acyl-COA dehydrogenase, eno~l-CoA with aggravation of her muscular weakness and failure to thrive.
On amval she looked exhausted, but was normally conscious.
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ROCCHICCIOLI ET A L opathy. She had a profound weakness and no active movement of the limbs against gravity. She remained in a frog leg position and had a poor cry. The face was inexpressive but without involvement of the extraocular muscles. The chest was flat with limited thoracic ampliation and unadapted respiratory efforts. Upper and lower limb muscles were severely atrophic and tendon reflexes could not be elicited. A gallop rhythm was noted, with a grade 2 systolic murmur and a rate of 150-180 beats per min. Systolic blood pressure was 70 mm Hg. Chest radiograph showed cardiomegaly with prominent left ventricle and a cardiothoracic index of 0.60. The ECG demonstrated peaked T waves in midprecordium and left ventricular hypertrophy.
Laboratory results included a plasma glucose of 72 mg/dL (4 mmol/L) and normal potassium, sodium, and chloride. Bicarbonate was 27 mmol/L, urea nitrogen 6.1 mmol/L, blood ammonia 143 hmol/L, hematocrit 37%, and white-cell count 89001 mm3. No ketones were detectable in the urine. Aspartate transaminase was 3 1 IU/L (n < 25), alanine transaminase 77 IU/L (n < 45), and bilirubin 3.5 mmol/L. Creatine phosphokinase was 606 IU/L (n < 120) and lactate dehydrogenase 650 IU/L (n < 240). Plasma insulin was 6 pU/mL, cortisol 23 hg/dL.
A two-dimensional echocardiogram demonstrated a dilated, poorly contracting left ventricle, with minor aortic and mitral regurgitation. A urine specimen at the time of admission showed elevated concentrations of dicarboxylic acids (see Results). After a short fast, a blood specimen was obtained for measurement of glucose, lactate, FFA, P-hydroxybutyrate, and carnitine levels (see Results). The day after arrival, the child required mechanical ventilation. She was given i.v. glucose and L-carnitine at a dose of 200 mg/kg per d. Her condition thereafter rapidly deteriorated, and despite aggressive ressuscitation, the child died 24 h later with acute cardiac decompensation.
MATERIALS AND METHODS
Because of the severity of the child's status at arrival, metabolic studies were limited to a 6-h fast to get fasting values of the major circulating substrates, during which blood glucose levels were monitored frequently to avoid hypoglycemia.
Blood glucose, lactate, pyruvate, P-hydroxybutyrate, and plasma FFA concentrations were determined as previously described (14) . Plasma carnitine levels were measured with a photometric method (1 5). Urine organic acids were measured as the trimethylsilyl derivatives by gas liquid chromatography-mass spectrometry (1 6).
Liver and skeletal muscle tissues were immediately collected after death, fixed in parafin for light microscopy or fixed in glutaraldehyde for electron microscopy (1 7).
Oxidation of [l-14C]palmitic, octanoic, and succinic acids to C 0 2 by fibroblasts was measured as described previously (1 8).
Acyl-CoA dehydrogenase activity for palmitic, octanoic, and succinic CoA esters was carried out essentially as described by Coates et al. (5) . The activity of 3-hydroxyacyl-CoA dehydrogenase for acetoacetyl-CoA, 3-keto-octanoyl-CoA and 3-keto-hexadecanoyl-CoA and the activity of 3-ketoacyl-CoA thiolase were measured in homogenates of cultured fibroblasts as recently described (1 9).
RESULTS
After not being fed for 6 h, the child had normal blood glucose (65 mg/dL, 3.6 mmol/L), low P-hydroxybutyrate concentration (0.07 mmol/L) with regard to rather elevated FFA (0.8 1 mmol/ L), and lactate slightly above the upper limit of normality (3.75 mmol/L). Plasma total carnitine concentration was decreased (22 Fmol/L, n > 40) with elevated urinary excretion (9.8 moll mol creatinine, n < 0.05). Table 1 shows the urinary concentrations of acetoacetate, P-hydroxybutyrate, medium-chain dicarboxylic acids, and other metabolites derived from the abnormal catabolism of FFA in the patient. Although acetoacetate and Phydroxybutyrate concentrations were low, suggesting an impairment of hepatic ketogenesis, the urinary dicarboxylic acids were markedly elevated in the patient. In addition, Cs to C14 dicarboxylic acids hydroxylated in 3-position were identified by mass spectrometry analysis in the patient's urine (Fig. 2) .
Light microscopy of the liver showed moderate portal fibrosis with micro-and macrovesicular steatosis. In addition to the presence of numerous neutral fat droplets, electron microscopy showed enlarged mitochondria with abnormal cristae in the hepatocytes (Fig. 3) . The other organelles including peroxisomes showed no qualitative alterations. Light microscopy of skeletal muscle showed abnormal variation of type I and type I1 fibers with moderate evidence of lipid storage. Electron microscopy showed an increased number of mitochondria with abnormal cristae between the myofibrills (Fig. 4) .
The data shown in Table 2 indicate that the oxidation of [ l -14C]palmitic acid by the patient's cultured fibroblasts is reduced to 45% of normal and that of [l-I4C] octanoate is reduced to 53% of normal. These values are similar to those reported in LCAD deficiency (2) . However, with the electron transfer flavoprotein-based assay, we found that LCAD as well as MCAD and SCAD activities were within the normal range. Activity measurement of 3-ketoacyl-CoA thiolase using acetoacetyl-CoA as substrate was also normal. Although 3-hydroxyacyl-CoA dehydrogenase showed normal activity for acetoacetyl-CoA, its activity was reduced to 42% of the normal mean with 3-ketooctanoylCoA, a value close to -2 SD of the control group, and to 27% with 3-ketohexadecanoyl-CoA substrates, a value well below the normal range.
DISCUSSION
Our study describes a metabolic disorder of mitochondria1 fatty acid oxidation associated with deficient activity of longchain 3-hydroxyacyl-CoA-dehydrogenase. The clinical manifestations in our patient resemble the severe forms of LCAD deficiency in the following: multiple episodes of coma and hypoglycemia, striking involvement of cardiac and skeletal muscles, early onset within the first months of age, and poor prognosis (2, 6). However, patients with 3-hydroxyacyl-CoA dehydrogenase defi-660 ROCCHICCIOLI ET AL. The urinary organic profile reveals reduced ketogenesis and dicarboxylic aciduria, characteristic of a defect of hepatic fatty acid oxidation. As reported in patients with LCAD and MCAD, the low circulating plasma level of carnitine observed in our patient is likely to be a consequence of the defect of hepatic fatty acid oxidation (1, 2). The administration of carnitine because of our initial suspicion of carnitine deficiency did not reverse the rapidly fatal course of the cardiac decompensation. We even questioned whether it could have aggravated the situation, through an increase in the generation of possibly toxic longchain dicarboxylic compounds. We were not able to confirm nor eliminate this hypothesis, which should therefore be kept in mind for the management of other patients with similar clinical syndromes.
In addition to the C6 to C10 dicarboxylic aciduria observed in most, if not all (8, 20) , reported cases of deficient P-oxidation, our patient excreted longer-chain C,2 and C I 4 dicarboxylic acids with a hydroxyl group in 3-position. These compounds, not found in patients with LCAD deficiency, were reported in the urine of one patient with similar clinical presentation (8), who was proven subsequently to have a defect in fatty acid oxidation at the level of long-chain 3-hydroxyacyl-CoA dehydrogenation (20) . This deficiency has been demonstrated in the cultured fibroblasts of our patient. There are two mitochondrial enzymes called 3-hydroxyacyl-CoA dehydrogenases, which catalyze the oxidation of the hydroxy group to a keto group in a NAD' dependent reaction. There is evidence to support the existence of two chain-length-specific 3-hydroxyacyl-CoA dehydrogenase enzymes in mammalian tissues, one being specific for shortchain substrates, the other for medium-and long-chain substrates (21, 22) . Our patient had a combined defect of both palmitic (CL6) and octanoic (C*) acid oxidation, demonstrable in her cultured fibroblasts. Whereas palmitic acid oxidation takes place in both mitochondria and peroxisome, the oxidation of octanoate is almost uniquely mitochondrial (23) . We first established that the patient's defect in fatty acid oxidation was not due to a deficiency of any of the acyl-CoA dehydrogenases nor to a defect of 3-ketoacyl-CoA thiolase. With the use of a specific substrate, 3-ketohexadecanoyl-CoA, we found that the deficient step was at the level of long-chain 3-hydroxyacyl-CoA dehydrogenase. Because of the overlapping chain-length specificity of this enzyme with the short-chain 3-hydroxyacyl-CoA dehydrogenase, substrates such as 3-ketooctanoyl-and 3-ketodecanoyl-CoA can be partially oxidized.
Therefore, the oxidation of the long-chain acyl-CoA derived from the predominant Clh to C18 plasma fatty acids cannot continue beyond their hydroxylation in 3-position (Fig. 1) . The resulting Cg to CI4 3-hydroxyacyl-COA esters can leave the mitochondria, then undergo o-oxidation in the microsomes and form the 3-hydroxy-dicarboxylic acids observed in the patient's urine. Alternatively, the Cl6 and CIg 3-hydroxylated compounds can be shortened by four to eight carbon atoms through the peroxisomal p-oxidation. The residual activity observed with 3-keto-hexadecanoyl-CoA (27%) is likely the reflection of the activity of the peroxisomal bifunctional protein toward this substrate (24) .
In conclusion, it is important to point out the clinical and biochemical similarities between our observation and other defects in fatty acid oxidation, such as LCAD deficiency (2, 6) , systemic carnitine deficiency (25) , and carnitine-palmityltransferase deficiency (26) . The muscular and cardiac involvement observed in our patient is consistent with the hypothesis that the accumulation of long-chain dicarboxylic acids, which occurs in all of these disorders, is directly toxic to these tissues (6) . Another contributory mechanism to the predominant expression of the mitochondrial defect in muscle and heart can be the limited capacity of the alternative pathway of fatty acid peroxisomal /3-oxidation in these tissues versus the liver (27) , resulting in a more complete defect of the lipid-derived energy production.
